Literature DB >> 12840684

Candida oesophagitis with hepatitis C virus: an uncommon association.

Javed Yakoob1, Wasim Jafri, Akbar S Hussainy.   

Abstract

Candida oesophagitis is an acquired immune deficiency syndrome (AIDS)-defining illness. We report a 28-year-old woman who presented with Candida oesophagitis with underlying chronic hepatitis C. The patient presented with anorexia and weakness and was noted to have raised serum transaminases. Upper-gastrointestinal endoscopy revealed Candida oesophagitis involving the whole oesophagus. Oesophageal biopsy demonstrated changes consistent with Candida oesophagitis. Serology was positive for hepatitis C antibodies, and polymerase chain reaction (PCR) genotyped hepatitis C virus (HCV) as genotype 3. Liver biopsy revealed chronic hepatitis with moderately active portal inflammation. A human immunodeficiency virus (HIV) test was non-reactive for types 1 and 2. The development of Candida oesophagitis in a patient with chronic HCV infection demands prompt consideration of general debility and immunosuppression as effects of HCV that led to an occurrence of opportunistic infection. Evaluation of this case provides insight into various mechanisms of immune suppression associated with HCV infection.

Entities:  

Mesh:

Year:  2003        PMID: 12840684     DOI: 10.1097/00042737-200306000-00019

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta.

Authors:  Caroline H T Hall; Rachel Kassel; Robert S Tacke; Young S Hahn
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

2.  Epidemiology, prevalence, and associated factors of oral candidiasis in HIV patients from southwest Iran in post-highly active antiretroviral therapy era.

Authors:  Maryam Erfaninejad; Ali Zarei Mahmoudabadi; Elham Maraghi; Mohammad Hashemzadeh; Mahnaz Fatahinia
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

3.  Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure.

Authors:  Dan Li; Liang Chen; Xian Ding; Ran Tao; Yong Xin Zhang; Jie Fei Wang
Journal:  BMC Gastroenterol       Date:  2008-07-31       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.